AGOMELATINE VERSUS ESCITALOPRAM IN MAJOR DEPRESSIVE DISORDERS : A RANDOMIZED DOUBLE-BLIND, LONG TERM STUDY FOCUSING ON SLEEP SATISFACTION AND EMOTIONAL BLUNTING

Documents similaires

• Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial.
  par: Corruble, E, et autres
  Publié: (2013)
• Escitalopram versus other antidepressive agents for depression.
  par: Cipriani, A, et autres
  Publié: (2009)
• Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
  par: Goodwin, G, et autres
  Publié: (2009)
• Clinical studies on the efficacy of agomelatine on depressive symptoms.
  par: Goodwin, G
  Publié: (2009)
• Effects of escitalopram therapy on functional brain controllability in major depressive disorder
  par: Fang, F, et autres
  Publié: (2022)